WestGene Biopharma Presents Groundbreaking mRNA Vaccine Data at ESMO 2024
WestGene Biopharma, a leading innovator in mRNA therapeutics, presented the latest clinical data for its EBV-positive tumour ...
Pharmaceutical Technology11d
CD30 by Wuhan Bio-Raid Biotechnology for T-Cell Lymphomas: Likelihood of Approval
CD30 is under clinical development by Wuhan Bio-Raid Biotechnology and currently in Phase I for T-Cell Lymphomas.
Pharmaceutical Technology11d
CD30 by Wuhan Bio-Raid Biotechnology for T-Cell Leukemia: Likelihood of Approval
CD30 is under clinical development by Wuhan Bio-Raid Biotechnology and currently in Phase I for T-Cell Leukemia.
Medscape15d
Diagnosis and Management of Natural Killer-cell Malignancies
Pathologically, NK-cell lymphomas are divided into extranodal NK-/T-cell lymphoma, nasal type and aggressive NK-cell leukemia by the WHO classification. Clinically, NK-cell lymphomas can be ...